University of Leeds-led consortium appointed by HQIP to establish the National Registry for Robotically Assisted Surgery, with Ledidi supplying the registry technology
Ledidi AS has been selected as the data platform provider for England’s National Registry for Robotically Assisted Surgery (NRRAS), a new £1 million national clinical registry commissioned by the Healthcare Quality Improvement Partnership (HQIP) on behalf of NHS, and that has been awarded to a consortium led by the University of Leeds.
Robotically assisted surgery has been adopted rapidly across the NHS over the past decade, but there has been no single national record of how patients fare afterwards. Due to start in 2027, the registry aims to record every NHS operation in England that uses a surgical robot for orthopaedic and soft tissue surgery, capturing prospective outcome data on each procedure.
The registry is designed to address evidence gaps identified by the National Institute for Health and Care Excellence (NICE) in its early value assessments of robot-assisted orthopaedic and soft tissue procedures. Rather than relying on single-centre studies, clinicians, commissioners and regulators will have comparable outcome data across the healthcare providers — including where results vary, and where access to robotic surgery is unequal. It will collect information on all 11 types of surgical robots in use today, and add new systems as they come into use, treating every manufacturer and every robot manufacturer equally.
The consortium brings together the University of Leeds as clinical and academic lead, the University of Warwick leading the orthopaedic workstream, and Ledidi as data platform provider, supported by a clinical reference group drawn from the relevant surgical specialties and by patient representatives. The registry will be developed in alignment with NICE, NHS England, the Medicines and Healthcare products Regulatory Agency and the National Equipment Tracking and Information System.
Ledidi's role within the consortium is to provide the registry platform, Ledidi Registries, to enable structured data capture at participating NHS sites, linkage to other national datasets, and near real-time analysis and reporting for each stakeholder group. Clinical and academic leadership rests with the University of Leeds and the University of Warwick. Ledidi holds no controllership of registry data and has no role in deciding who may access it or in approving published outputs, which sit with an independently chaired programme board including HQIP and NHS England. Information in NRRAS will be kept separate from other registries, only approved people will be able to access it, and a full record will be kept of who has used it. No company will be given registry information for its own commercial gain.
"Good-quality data is essential if new surgical technology is to lead to better results for patients, and if everyone across the NHS is to have fair access to it. Ledidi is proud to provide the technology and to help build a registry that will give doctors and policymakers the evidence they need to guide the use of robotic surgery in the NHS for the long term."
Dr Einar Martin Aandahl, Chief Executive, Ledidi
"Robotic surgery has been around for more than 20 years, but its use is now growing fast and it is being used to treat more and more conditions. We need to collect information about these operations so that patients get the best treatment and the NHS gets good value for its money."
Professor David Jayne, Clinical Lead, University of Leeds
"We’re delighted to be working with Leeds and Ledidi on this exciting new registry. We expect what we learn from it to make a big difference to patient care and research, and to help us keep up with the fast pace of change in robotic surgery. The registry will also help the UK stay a world leader in developing new surgical technology."
Professor Andrew Metcalfe, University of Warwick
Read the University of Leeds announcement of 10 November 2026.
About Ledidi
Ledidi AS is a Norwegian health technology company. Its platform enables secure health data capture, collaboration and analysis across clinical research, national registries and clinical trials, helping healthcare providers and life science organisations generate real-world evidence and meet regulatory and information-governance obligations. Ledidi holds ISO 27001, SOC 2 Type II and HIPAA attestation, alongside conformance with the NHS Data Security and Protection Toolkit, Cyber Essentials and DTAC.
